{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:33:41Z","timestamp":1790782421787,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jacc.2014.05.049","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T19:45:48Z","timestamp":1408995948000},"page":"863-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"64","author":[{"given":"Katharina","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Bernlochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegmund","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Orban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Morath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisena","family":"Cala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hoppmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Sibbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.05.049_bib1","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A\u00a0prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/hrt.2010.220491","article-title":"High on-treatment platelet reactivity to both aspirin\u00a0and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention","volume":"97","author":"Breet","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2014.05.049_bib4","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.049_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MBC.0b013e3282f9ade8","article-title":"Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study","volume":"19","author":"Christiaens","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2014.05.049_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcin.2010.05.014","article-title":"Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets","volume":"3","author":"Wurtz","year":"2010","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2014.05.049_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjcard.2009.04.015","article-title":"Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis","volume":"104","author":"Pinto Slottow","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1160\/TH08-06-0374","article-title":"Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function","volume":"100","author":"Gori","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.05.049_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2014.05.049_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2014.05.049_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2007.12.010","article-title":"Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events\u2014a meta-analysis","volume":"128","author":"Sofi","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.05.049_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.pharmthera.2006.05.011","article-title":"Aspirin resistance: truth or dare","volume":"112","author":"Lordkipanidze","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacc.2014.05.049_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-9560-3-10","article-title":"Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels","volume":"3","author":"Borna","year":"2005","journal-title":"Thromb J"},{"key":"10.1016\/j.jacc.2014.05.049_bib15","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2005.05.090","article-title":"Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation","volume":"46","author":"Tantry","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.coph.2012.12.004","article-title":"Aspirin and aspirin resistance in coronary artery disease","volume":"13","author":"Kasmeridis","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jacc.2014.05.049_bib17","series-title":"Der Kardiologe","article-title":"Pl\u00e4ttchenaggregationshemmer","author":"Sibbing","year":"2012"},{"key":"10.1016\/j.jacc.2014.05.049_bib18","first-page":"51","article-title":"Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers","volume":"6","author":"Nagelschmitz","year":"2014","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.jacc.2014.05.049_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/clc.4960230912","article-title":"Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes","volume":"23","author":"Gurfinkel","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1213\/ane.0b013e3181a27d10","article-title":"Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction","volume":"109","author":"Jambor","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2014.05.049_bib21","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.049_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2014.05.049_bib23","unstructured":"Harrell FE Jr, et\u00a0al. Harrell Miscellaneous. R package version 3.10-1. 2012. Available at: http:\/\/CRAN.R-project.org\/package=Hmisc. Accessed January 7, 2014."},{"key":"10.1016\/j.jacc.2014.05.049_bib24","series-title":"Predicting Outcomes: Applied Survival Analysis and Logistic Regression","author":"Harrell","year":"1997"},{"key":"10.1016\/j.jacc.2014.05.049_bib25","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study","volume":"56","author":"Erbel","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1012592","article-title":"Carotid-wall intima-media thickness and cardiovascular events","volume":"365","author":"Polak","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.049_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11239-006-8952-4","article-title":"The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events","volume":"22","author":"Pamukcu","year":"2006","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2014.05.049_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.049_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-6-47","article-title":"\u201cAspirin resistance\u201d or treatment non-compliance: which is to blame for\u00a0cardiovascular complications?","volume":"6","author":"Shantsila","year":"2008","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jacc.2014.05.049_bib32","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A\u00a0systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.05.049_bib33","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.049_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2014.05.049_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ahj.2012.04.001","article-title":"Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature","volume":"164","author":"Berger","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.05.049_bib36","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.049_bib37","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/CIRCULATIONAHA.105.596627","article-title":"Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of\u00a0aspirin resistance","volume":"113","author":"Frelinger","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.049_bib38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.849166","article-title":"Cardiovascular risk prediction: basic concepts, current status, and future directions","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714042454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714042454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T08:50:49Z","timestamp":1565772649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714042454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0735109714042454"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.05.049","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}